Lessons for the clinical nephrologist: an uncommon cause of pulmonary-renal syndrome.


Journal

Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268

Informations de publication

Date de publication:
06 2021
Historique:
received: 09 07 2020
accepted: 17 08 2020
pubmed: 2 9 2020
medline: 23 7 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

Pulmonary-renal syndrome refers to the combination of elevated plasma creatinine concentration and/or abnormal urinalysis with diffuse alveolar hemorrhage, and involves both an urgent diagnostic approach and care. We report the case of a 24-year-old man presenting with diffuse alveolar hemorrhage as well as a nephritic syndrome associating kidney failure, moderate hypertension, hematuria and selective glomerular proteinuria. The initial high suspicion of anti-glomerular basement membrane (GBM) disease or ANCA-associated vasculitis justified intravenous pulse-corticotherapy in association with plasma exchange. Renal biopsy was remarkable for an IgA nephropathy, lesions of active thrombotic microangiopathy (TMA) and a positive staining for complement factor C4d. Because anti-GBM and ANCA antibodies returned negative, plasma exchange was discontinued, but oral corticosteroids were maintained to prevent alveolar hemorrhage recurrence. In the absence of renal function recovery, hemodialysis was initiated. TMA lesions are frequently seen in IgA nephropathy and are associated with a poorer prognosis. Complement activation seems to be involved in the development of those lesions and contributes to disease progression. Conversely, alveolar hemorrhage in the setting of IgA nephropathy is uncommon. It is thought to result from non-specific mucosal hemorrhage, an immune complex mediated basement membrane damage and an IgA-mediated capillaritis against basement membrane antigens.

Identifiants

pubmed: 32870493
doi: 10.1007/s40620-020-00846-6
pii: 10.1007/s40620-020-00846-6
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

935-938

Références

Gallagher H, Kwan J, Jayne RW (2002) Pulmonary renal syndrome: a 4-year, single center experience. Am J Kidney Dis 38:42–47
doi: 10.1053/ajkd.2002.29876
West SC, Arulkumaran N, Ind PW, Pusey CD (2013) Pulmonary-renal syndrome: a life threatening but treatable condition. Postgrad Med J 89(1051):274–283
doi: 10.1136/postgradmedj-2012-131416
Collard HR, Schwarz MI (2004) Diffuse alveolar hemorrhage. Clin Chest Med 25:583–592
doi: 10.1016/j.ccm.2004.04.007
Rajagopala S, Parameswaran S, Ajmera JS, Ganesh RN, Katrevula A (2017) Diffuse alveolar hemorrhage in IgA nephropathy: case series and systematic review of the literature. Int J Rheum Dis 20:109–121
doi: 10.1111/1756-185X.12818
Ito Y, Arita M, Kumagai S et al (2018) Diffuse alveolar hemorrhage in IgA vasculitis with an atypical presentation. Intern Med 57:81–84
doi: 10.2169/internalmedicine.8984-17
Miyazaki S, Hattori A, Kuno Y et al (2018) IgA nephropathy with diffuse alveolar haemorrhage. BMJ Case Rep 11(1):e227382. https://doi.org/10.1136/bcr-2018-227382
doi: 10.1136/bcr-2018-227382 pubmed: 30580306 pmcid: 6350714
El Karoui K, Hill GS, Karras A et al (2012) A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol 23:137–148
doi: 10.1681/ASN.2010111130
Cai Q, Shi S, Wang S et al (2019) Microangiopathic lesions in IgA nephropathy: a cohort study. Am J Kidney Dis 74(5):629–639
doi: 10.1053/j.ajkd.2019.03.416
Chua J, Zandbergen M, Wolterbeek R et al (2019) Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis. Mod Pathol 32(8):1147–1157
doi: 10.1038/s41379-019-0259-z

Auteurs

Quentin Binet (Q)

Department of Nephrology, Grand Hôpital de Charleroi, Gilly, Belgium. quentin.binet@student.uclouvain.be.

Selda Aydin (S)

Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Jean-Philippe Lengele (JP)

Department of Nephrology, Grand Hôpital de Charleroi, Gilly, Belgium.

Jean-François Cambier (JF)

Department of Nephrology, Grand Hôpital de Charleroi, Gilly, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH